Deadline: January 7, 2028

Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effort to identity targets for future development of novel treatment interventions. Offered by National Institutes of Health; applications due January 7, 2028.

Key Facts

Funder
National Institutes of Health
Award amount
Not specified by funder
Deadline
January 7, 2028
Geography
United States
Categories
Healthcare
Status
Open

About This Grant

The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effort to identity targets for future development of novel treatment interventions. This funding opportunity aims to advance novel and innovative translational research to...

Full requirements and application instructions: official listing.

Similar Open Grants

Deadlines Move. Your Search Shouldn't Start Over.

Get matched to open grants by eligibility and track every deadline in one workspace.